The story of Viagra, and its parent company copyright, presents a intriguing case study for investors. Initially a blockbuster drug, generating billions in revenue , its intellectual property lapse created a deluge of knock-off medications, significantly diminishing its dominance. While specific businesses may attempt to capitalize on similar co… Read More